SCHEMBL23061396

SCHEMBL23061396

c1cncc(-c2cnnc(-c3cncnc3)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.60
GABRG2 P18507 6/20 0.55
GABRB3 P28472 6/20 0.55
GABRA5 P31644 6/20 0.55
GABRA3 P34903 6/20 0.55
GABRA1 P14867 5/20 0.55
ALDH1A1 P00352 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP19A1 P11511 2/20 0.46
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855823 0.88 GABRG2 (0.72) CYP2A6GABRG2GABRB3GABRA5GABRA3
SCHEMBL2653411 0.83 GABRG2 (0.66) CYP2A6GABRG2GABRB3GABRA5GABRA3
SCHEMBL2074501 0.79 CYP2A6 (0.54) CYP2A6GABRG2GABRB3GABRA5GABRA3
SCHEMBL30338888 0.77 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL3614263 0.77 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL20267348 0.75 CYP2A6 (0.54) CYP2A6GABRG2GABRB3GABRA5GABRA3
Pyrimidine SCHEMBL28261125 0.74 CYP2A6 (0.85) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL10835353 0.74 CYP2A6 (0.62) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL28013979 0.74 CYP2A6 (0.83) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL30297729 0.74 CYP2A6 (0.50) CYP2A6ALDH1A1CYP1A2CYP3A4CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11427560-B2 Composition and methods for inhibiting mammalian sterile 20-like kinase 1 THE SCRIPPS RESEARCH INSTITUTE (US) 2022-08-30 US disclosed
US-20210061784-A1 COMPOSITION AND METHODS FOR INHIBITING MAMMALIAN STERILE 20-LIKE KINASE 1 UNIVERSITÄT BREMEN (DE) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061784-A1 COMPOSITION AND METHODS FOR INHIBITING MAMMALIAN STERILE 20-LIKE KINASE 1 TESK2, TESK1, PRKACB CYP2A6 4768/4885GABRG2 3445/4885GABRB3 2852/4885
US-11427560-B2 Composition and methods for inhibiting mammalian sterile 20-like kinase 1 TESK2, TESK1, PRKACB CYP2A6 4768/4885GABRG2 3445/4885GABRB3 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.